BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,168,000 | +6.9% | 986,000 | -0.7% | 0.00% | -100.0% |
Q1 2018 | $1,093,000 | -66.3% | 993,000 | -63.3% | 0.00% | -50.0% |
Q3 2017 | $3,242,000 | +209.1% | 2,709,000 | +207.1% | 0.00% | +100.0% |
Q2 2017 | $1,049,000 | -79.7% | 882,000 | -79.8% | 0.00% | -75.0% |
Q1 2017 | $5,161,000 | +154.1% | 4,372,000 | +152.1% | 0.00% | +100.0% |
Q4 2016 | $2,031,000 | -63.4% | 1,734,000 | -61.0% | 0.00% | -50.0% |
Q3 2016 | $5,547,000 | +1359.7% | 4,450,000 | +1252.6% | 0.00% | – |
Q2 2016 | $380,000 | -86.6% | 329,000 | -86.2% | 0.00% | -100.0% |
Q1 2016 | $2,833,000 | +2148.4% | 2,390,000 | +2415.8% | 0.00% | – |
Q4 2015 | $126,000 | -96.5% | 95,000 | -96.5% | 0.00% | -100.0% |
Q3 2015 | $3,607,000 | +2273.0% | 2,685,000 | +2696.9% | 0.00% | – |
Q2 2015 | $152,000 | +11.8% | 96,000 | +6.7% | 0.00% | – |
Q1 2015 | $136,000 | +23.6% | 90,000 | 0.0% | 0.00% | – |
Q4 2014 | $110,000 | -16.0% | 90,000 | -25.0% | 0.00% | – |
Q3 2014 | $131,000 | -68.1% | 120,000 | -69.3% | 0.00% | – |
Q2 2014 | $411,000 | +85.1% | 391,000 | +95.5% | 0.00% | – |
Q1 2014 | $222,000 | +29.8% | 200,000 | +23.5% | 0.00% | – |
Q4 2013 | $171,000 | – | 162,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
IRON Financial LLC | 460,000 | $513,000 | 0.40% |
Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |